Fragile X syndrome is a genetic condition that affects learning, behavior, and development. Many people with Fragile X syndrome have developmental delays, speech and language differences, and features like anxiety or attention challenges. It is lifelong, and signs are often noticed in early childhood, though they can vary by age and between males and females. Treatment focuses on supportive therapies such as speech, occupational, and behavioral therapy, and some may use medicines for attention, mood, or seizures. The outlook varies, but many people with Fragile X syndrome benefit from early support and coordinated care.
Overview
Fragile x syndromeSymptoms
Fragile X syndrome features often appear in early childhood: developmental and speech delays, learning challenges, social anxiety, sensory sensitivities, and attention or autism-like behaviors. Some have flexible joints, long face or large ears, and, less often, seizures.
Outlook and prognosis
Most people with Fragile X syndrome grow and learn across their lifetime, though at their own pace. Early support—speech, educational, behavioral, and, when needed, medicines—can improve communication, learning, and daily independence. Adults often need some support but can build meaningful routines and relationships.
Causes and risk factors
Fragile X syndrome stems from a CGG repeat expansion in FMR1 on the X chromosome, inherited. Risk factors for Fragile X syndrome include family history and premutation carrier status; males are more affected. No environmental or lifestyle causes are known.
Genetic influences
Genetics is central in Fragile X syndrome: it’s caused by a change in the FMR1 gene on the X chromosome. The size of the gene’s repeat expansion and methylation level shape severity and features. Family members may carry premutations, affecting reproductive risks and tremor/ataxia later.
Diagnosis
Doctors suspect Fragile X syndrome from developmental delays, learning challenges, or a family history. The genetic diagnosis of Fragile X syndrome is confirmed by a blood test that checks the FMR1 gene’s CGG-repeat expansion. Prenatal testing is available.
Treatment and drugs
Treatment for Fragile X syndrome focuses on building skills and easing day-to-day challenges. Care often combines speech and language therapy, educational support, behavioral strategies, and, when needed, medicines for attention, anxiety, irritability, or sleep. Regular hearing, vision, and developmental checks help guide adjustments.
Symptoms
Families often notice developmental and communication differences in infancy or early childhood. Parents often ask about early features of Fragile X syndrome, such as delayed milestones, language delays, or sensory sensitivities that affect daily routines. These traits can range from mild learning differences to more significant challenges with behavior and social connection. Features vary from person to person and can change over time.
Many children with Fragile X syndrome learn skills later than peers, especially problem-solving and school-based learning. Supportive teaching and early therapies can help build skills. Severity can be milder in girls.
Speech may start later and progress slowly, with pronunciation and expressive language lagging. People with Fragile X syndrome may also struggle to find words or follow complex instructions. Speech therapy can improve clarity and communication.
Crowds, new places, or direct eye contact can feel overwhelming. Many with Fragile X syndrome may avoid eye contact or hang back in groups, even when they want to join. Gentle support and predictable routines can ease stress.
Loud sounds, bright lights, or certain textures can trigger discomfort or distress. This can lead to covering ears, meltdowns, or pulling away from touch. Occupational therapy can teach coping strategies.
How people usually first notice Fragile x syndrome?
Many families first notice Fragile X syndrome when a baby doesn’t meet early milestones as expected, such as limited eye contact, low muscle tone, or delayed babbling and first words; these early developmental differences often become clearer in the toddler years. As children grow, the first signs of Fragile X syndrome may include speech and language delay, sensory sensitivities, hand‑flapping, trouble with transitions, or behavioral features like anxiety and attention difficulties, and some boys may show physical traits such as larger ears or flexible joints. For many, Fragile X is first recognized during developmental screening or early intervention evaluations, which then prompts genetic testing to confirm the diagnosis.
Types of Fragile x syndrome
Fragile X syndrome has more than one clinical variant, largely tied to how much the FMR1 gene is altered and whether the gene is switched off in all or only some cells. These variants help explain why symptoms can range from subtle learning differences to more noticeable developmental and behavioral features. Not everyone will experience every type. Understanding the main variants of Fragile X syndrome can clarify how symptoms may differ and what to expect when discussing types of Fragile X syndrome with your care team.
Full mutation
This is the classic form where the FMR1 gene is largely silenced. Many have developmental delay, learning challenges, and social or behavioral differences. Features can be more pronounced in males and often milder in females.
Premutation carrier
People carry a moderate expansion in FMR1 but not the full mutation. Most children do not have the full Fragile X syndrome picture, though some may have anxiety, attention, or learning differences. In adulthood, some carriers are at risk for carrier-related conditions.
Mosaicism
Some cells have the full mutation while others have a premutation or normal range. Symptoms may be milder or more variable from day to day or between skills. The mix of cell types can lead to a wide range in learning, behavior, and physical features.
Female phenotype
People who have two X chromosomes may show a wide range of impact. Many have subtler learning or attention differences, while some have more noticeable features. The degree of X‑chromosome inactivation can influence symptom severity.
What genetics can tell you about symptoms
Some people with Fragile X syndrome who have full FMR1 gene “full mutations” (silenced gene) tend to have more pronounced learning differences, speech delays, anxiety, and features like hand‑flapping or sensory sensitivity. Those with premutations may have milder learning or mood issues, while some adults develop tremor or balance problems.
Causes and risk factors
Fragile X syndrome is caused by a change in the FMR1 gene on the X chromosome, either inherited or new. A repeated DNA segment expands and switches this gene off. Some risks are written in our DNA, passed down through families. Risk is higher with a mother who carries an FMR1 premutation, and males often have more severe features. Environment and lifestyle do not cause the condition or the early symptoms of Fragile X syndrome, but they can shape how learning and behavior challenges show up over time.
Environmental and biological risk factors
Many families first notice early symptoms of Fragile X syndrome during routine developmental checkups. It’s just as important to understand which body-based or environmental factors do—and do not—change the chance of Fragile X syndrome occurring. Doctors often group risks into internal (biological) and external (environmental). For Fragile X syndrome, current research has not found clear links between common exposures or parental health factors and the likelihood of the condition.
Large studies have not shown that older maternal or paternal age increases the chance of Fragile X syndrome. Age can influence other pregnancy outcomes, but it does not appear to affect this condition.
Common conditions such as diabetes or thyroid disease have not been linked to a higher chance of this condition. These conditions may need careful management in pregnancy for other reasons.
Infections during pregnancy can sometimes affect fetal development, but they do not cause Fragile X syndrome. Standard infection prevention still protects overall pregnancy health.
Medicines taken as prescribed have not been shown to raise the risk of this condition. Always review medications with a clinician to balance benefits and safety.
Genetic risk factors
Fragile X syndrome stems from changes in a single gene on the X chromosome, most often a repeat expansion that switches the gene off. Some risk factors are inherited through our genes. Understanding genetic risk can guide monitoring for early symptoms of Fragile X syndrome. Family patterns, repeat length, and who passes the gene change on all shape individual risk.
FMR1 full mutation: The most common cause of Fragile X syndrome is a very large CGG repeat in the FMR1 gene on the X chromosome that switches the gene off. This reduces the gene’s protein, which is important for brain cell connections and learning.
Maternal premutation expansion: When a mother carries a premutation (a mid-sized CGG repeat), it can expand to a full mutation during egg formation. The chance of expansion rises as the premutation repeat number gets larger. This is the main genetic pathway to Fragile X syndrome.
Paternal transmission patterns: Fathers with a premutation typically pass it unchanged to daughters and not to sons. Their premutation rarely expands to a full mutation at conception.
CGG repeat size: Bigger repeat numbers carry a higher chance that a premutation will expand to a full mutation in the next generation. Intermediate ranges tend to stay stable, while larger premutations are more likely to grow. This directly raises the risk of Fragile X syndrome for children of female carriers.
AGG interruptions: Small stabilizing breaks within the CGG repeat, called AGG interruptions, can lower the chance of expansion. Fewer or no interruptions increases the odds that a premutation will become a full mutation in a child.
Family history: Having relatives with Fragile X syndrome, unexplained learning differences, early menopause, or late-onset tremor and balance problems can signal an inherited FMR1 change. This pattern points to a higher chance of being a carrier and passing the change on.
Biological sex effects: People with one X chromosome (typically males) are more likely to have marked features because there is no second X to offset the gene change. People with two X chromosomes (typically females) often have milder or mixed features due to the second X.
X-inactivation patterns: In females, which X chromosome is active in each cell can tilt symptom severity up or down. Skewed inactivation toward the X with the gene change tends to increase features. People with the same risk factor can have very different experiences.
Mosaicism: Some people have a mix of cells, with some carrying a full mutation and others a premutation or typical size. Mosaicism can soften features and sometimes lowers measured blood repeat sizes, which may affect test results.
Rare FMR1 variants: Uncommon deletions or small changes in the gene’s code can also cause Fragile X syndrome. These are less frequent than repeat expansions but can lead to similar clinical features.
New mutations: A gene change can appear for the first time in a family when a repeat expands from an intermediate or premutation range. This means Fragile X syndrome can appear even without a known family history.
Lifestyle risk factors
Lifestyle habits do not cause Fragile X syndrome, but they can meaningfully shape day‑to‑day functioning, behaviors, and health complications. In practice, how lifestyle affects Fragile x syndrome includes impacts on anxiety, sleep, attention, constipation, weight, and seizure control. Clinicians sometimes describe these as lifestyle risk factors for Fragile x syndrome because certain routines can aggravate or relieve symptoms. Tailoring daily habits can support learning, communication, and emotional regulation across childhood and adulthood.
Irregular or short sleep can intensify hyperactivity, irritability, and anxiety in Fragile X. Consistent bedtimes and calming wind‑down routines may improve behavior and reduce next‑day meltdowns.
Regular movement can lower anxiety, improve attention, and support motor coordination. It also helps prevent excess weight gain, which is common and can worsen reflux and joint discomfort.
A fiber‑rich, varied diet with adequate hydration can reduce constipation and reflux that often exacerbate discomfort and challenging behaviors. Limiting caffeine and high‑sugar foods may lessen jitteriness and sleep disruption.
Excessive or stimulating media can worsen attention problems, sleep latency, and arousal in Fragile X. Structured, time‑limited, and calming content may support self‑regulation.
Risk prevention
Fragile X syndrome is a genetic condition present from conception, so we can’t prevent it after a pregnancy has started. Prevention focuses on informed family planning and, for those living with Fragile X syndrome, lowering the chance of complications and supporting healthy development. Knowing your risks can guide which preventive steps matter most.
A genetics professional can explain how Fragile X runs in families and map out who else may benefit from testing. They can help you understand chances for future children and discuss options that fit your values.
If you’re planning a pregnancy, a simple blood test can check whether you carry changes in the FMR1 gene linked to Fragile X syndrome. Finding carriers before pregnancy allows time to consider reproductive choices.
In vitro fertilization with embryo testing (PGT-M) can select embryos without the full Fragile X change. Donor eggs or sperm are alternatives for some families who want to avoid passing on the condition.
During pregnancy, diagnostic tests like CVS (placental sampling) or amniocentesis (amniotic fluid testing) can check the baby’s FMR1 gene. These tests confirm whether the fetus has Fragile X syndrome so you can plan care early.
Transmission
Fragile X syndrome isn’t contagious—you can’t catch it from someone—because it’s passed down through families. The genetic transmission of Fragile X syndrome involves a change on the X chromosome, so women can pass the changed X to sons or daughters, while men pass their single X only to daughters. Most children with Fragile X syndrome inherit a “full mutation” that develops when a mother’s “premutation” expands as her eggs form; by contrast, men with a premutation usually pass it unchanged to their daughters and not to sons. Some people carry a premutation with few or no symptoms but can still pass on a larger expansion, and rarely a new expansion appears for the first time in a family.
When to test your genes
Test if you have a family history of Fragile X–related conditions, unexplained intellectual disability, autism features, or premature ovarian insufficiency. Consider testing before pregnancy or during fertility care to understand carrier status and reproductive options. Newborns or children with developmental delays may also benefit, guiding early supports and tailored care.
Diagnosis
For many families, the first clues come from developmental delays, learning challenges, or behavioral differences that prompt an evaluation. Early patterns on exam and history often point toward Fragile X syndrome, and a specific lab test can confirm it. Early and accurate diagnosis can help you plan ahead with confidence. The genetic diagnosis of Fragile X syndrome is made by testing the FMR1 gene in a blood or saliva sample.
A lab looks for an expanded CGG repeat and changes in methylation within the FMR1 gene. Finding a full mutation confirms Fragile X syndrome. Testing uses a blood or saliva sample.
Doctors review developmental milestones, learning profile, and behavior, and examine for features seen in Fragile X. This helps decide who should get FMR1 testing. It also guides supportive therapies while results are pending.
A detailed family and health history can help identify relatives with learning differences, autism, or related signs across generations. These patterns raise suspicion for Fragile X syndrome. They also help map who else might benefit from testing.
Relatives may choose testing to see if they carry an FMR1 premutation or full mutation. Results can clarify reproductive options and explain varied symptoms in the family. Genetic counseling is often recommended to review choices.
Stages of Fragile x syndrome
Fragile x syndrome does not have defined progression stages. It’s a lifelong neurodevelopmental difference; abilities and behaviors can change with age, but the condition doesn’t follow a step-by-step decline. Doctors look for early symptoms of Fragile x syndrome in infancy or early childhood, then track development, learning, and behavior over time through regular checkups and evaluations. Genetic testing may be offered to clarify certain risks, and a DNA test can confirm the diagnosis.
Outlook and prognosis
Daily life with Fragile X syndrome can range from mild learning differences to more significant challenges with communication, anxiety, and sensory overload. Everyone’s journey looks a little different. Early care can make a real difference, especially when speech therapy, educational supports, and behavior strategies start in preschool or earlier; many living with Fragile X syndrome gain new skills over time, even if progress is gradual.
Looking at the long-term picture can be helpful. Most people with Fragile X syndrome have a normal life span, and the condition itself isn’t typically life-limiting. Independence varies: some adults live with family or supported housing, while others manage semi-independent routines with structured help. Many people find that symptoms like social anxiety and hyperactivity ease somewhat with age, though learning challenges and communication differences usually persist.
In adulthood, medical concerns often relate to coexisting conditions rather than Fragile X syndrome alone. Seizures, if present in childhood, often improve by the teen years; sleep issues and anxiety can continue but are manageable. For families wondering about early symptoms of Fragile X syndrome and what they mean for the future, understanding the prognosis can guide planning and set realistic expectations for school, work programs, and community life. Talk with your doctor about what your personal outlook might look like, including supports that match current abilities and long-term goals.
Long-term effects
Fragile X syndrome can shape learning, communication, behavior, and physical health across the lifespan, and the picture can look different in childhood versus adulthood. Long-term effects vary widely, and they can differ between males and females. Many families first notice what people often call early symptoms of Fragile X syndrome—such as speech delay or motor delay—even though these are developmental features rather than short-term illnesses. Over time, patterns usually become clearer, and doctors may follow changes during school years, puberty, and adulthood.
Learning differences tend to persist into adulthood, with slower processing and challenges with abstract reasoning. Impact is often greater in males with Fragile X syndrome, while females may have milder learning issues.
Delayed speech and expressive language difficulties can continue, with fast or repetitive speech in some. Social communication—like back‑and‑forth conversation—may remain hard for many with Fragile X syndrome.
Ongoing attention problems and restlessness are common. Planning, organization, and impulse control may remain challenging and can affect school, work, and daily routines.
Social anxiety and worry can continue into adulthood. Some experience mood swings or irritability, especially during transitions or unfamiliar situations in Fragile X syndrome.
How is it to live with Fragile x syndrome?
Living with Fragile X syndrome often means building routines that reduce stress, using clear, consistent communication, and allowing extra time for learning new skills. Many people with Fragile X have sensory sensitivities, social anxiety, or attention challenges, so quiet spaces, visual supports, and predictable schedules can make daily life smoother at school, work, and home. Families, classmates, and coworkers may need to adjust expectations, break tasks into smaller steps, and celebrate progress in small increments, which can strengthen patience and teamwork. With early supports, therapies, and understanding networks, many find steady gains in communication, independence, and quality of life.
Treatment and drugs
Fragile X syndrome treatment focuses on easing symptoms, building skills, and supporting learning and behavior across childhood and adulthood. Supportive care can make a real difference in how you feel day to day, with speech and language therapy, occupational therapy for fine-motor and daily tasks, behavioral strategies, and educational supports tailored to each person’s strengths. Medicines may help with specific concerns—such as attention difficulties, anxiety, mood swings, sleep problems, or seizures—with a doctor adjusting the dose to balance benefits and side effects. For many, this can mean combining therapies at home and school with targeted medications, while checking in regularly to update the plan as needs change. Ask your doctor about the best starting point for you, and consider developmental and genetic specialist input to coordinate care over time.
Non-drug treatment
Living with Fragile X syndrome can affect communication, learning, behavior, and how the senses process everyday noise, touch, and change. Non-drug treatments often lay the foundation for steady progress by building practical skills and easing stress at home and school. Starting early and tailoring support over time usually leads to the best day-to-day results.
Starting services in infancy or preschool supports brain development and learning. Identifying early symptoms of Fragile X syndrome can speed access to speech, occupational, and behavior therapies. Regular check-ins help adjust goals as skills grow.
Sessions focus on speech clarity, understanding, and social communication. For people with Fragile X syndrome, therapists also work on pacing, stuttering-like dysfluency, and practical conversation skills.
Therapy builds fine-motor skills and everyday tasks like dressing, feeding, and handwriting. Sensory-friendly strategies can reduce overwhelm at home and school. Care plans are adapted to the child’s tolerance and interests.
Exercises improve balance, coordination, and posture for safer, easier movement. Targeted practice supports strength and flexibility for play, sports, and endurance.
Your genes may have an impact on how drugs work for you
Medicines for Fragile X syndrome can work differently based on inherited differences in genes that affect brain signaling and how the body processes drugs. Pharmacogenetic testing may guide dosing and medication choice, but clinical monitoring remains essential for safety and benefit.
Pharmacological treatments
Medicines don’t change the genetic cause of Fragile X syndrome, but they can ease day-to-day challenges like distractibility, anxiety, irritability, sleep trouble, and seizures. Choices are guided by your child’s or your top concerns and adjusted over time. Drugs that target symptoms directly are called symptomatic treatments. Some options can also help early symptoms of Fragile X syndrome such as hyperactivity and mood swings, especially when paired with therapies and steady routines.
Methylphenidate and mixed amphetamine salts can improve focus and reduce hyperactivity. Common effects include decreased appetite and trouble falling asleep. Doses are usually adjusted slowly to balance benefits and side effects.
Atomoxetine, guanfacine, or clonidine may help attention, impulsivity, and hyperactivity when stimulants are not tolerated or not enough. These can cause sleepiness or lower blood pressure, so monitoring is important. They may also smooth evening behavior without worsening sleep.
Fluoxetine, sertraline, or escitalopram can lower anxiety, social avoidance, and repetitive worries. Upset stomach or feeling more restless can occur early and often settle with time. Doses are started low and increased gradually.
This anti-anxiety option can ease worry and irritability without sedation for many. Dizziness or nausea can occur, especially at the start. It is often combined with behavioral strategies.
Genetic influences
Fragile X syndrome stems from a change in a single gene on the X chromosome, where a short stretch of DNA repeats too many times and effectively shuts the gene off. With the gene turned down, the brain makes too little of a protein that supports learning, attention, and behavior. Because this gene sits on the X chromosome, males are often more affected, while many females have milder features because they have a second X that can partly compensate. Some people carry a smaller expansion, called a premutation, and may have no learning differences themselves but can pass on a larger expansion to their children. Having a gene change doesn’t always mean you will develop the condition. When a mother carries a premutation, the repeat can grow when eggs are formed, raising the chance of a child with Fragile X syndrome; fathers with a premutation usually pass the same premutation to daughters without it expanding. A genetic test can measure the repeat length and whether the gene is switched off, helping families understand how Fragile X syndrome is inherited.
Is Fragile x syndrome genetic?
Genetics is central in Fragile X syndrome: it’s caused by a change in the FMR1 gene on the X chromosome. The size of the gene’s repeat expansion and methylation level shape severity and features. Family members may carry premutations, affecting reproductive risks and tremor/ataxia later.
Pharmacogenetics—how genetics influence drug effects
For families managing anxiety, attention, or irritability linked to Fragile X syndrome, genetics can influence which medicines help and at what dose. The FMR1 gene change that causes Fragile X shapes brain signaling, so researchers have explored drugs that act on those pathways, but for now most care focuses on treating symptoms such as ADHD, anxiety, sleep problems, or seizures. For commonly used medicines—SSRIs for anxiety, stimulants or atomoxetine for attention, certain antipsychotics for irritability, and some anti-seizure drugs—differences in other genes can affect how quickly your body breaks them down, which can influence side effects or benefit. Pharmacogenetic testing doesn’t give a “yes or no” answer, but it can help doctors adjust doses for medicines processed by enzymes such as CYP2D6 or CYP2C19. This may be useful, for example, with atomoxetine and many antidepressants (often tied to CYP2D6/CYP2C19), or with clobazam where CYP2C19 matters, aiming to reduce trial-and-error and side effects. If you’re considering pharmacogenetic testing for Fragile X syndrome, talk with your clinician about which current medicines—or future options—the results would inform, since test results are only one piece of the picture alongside age, other health conditions, and behavioral supports.
Interactions with other conditions
Day to day, the challenges of Fragile X syndrome often reflect how it overlaps with other conditions. Doctors call it a “comorbidity” when two conditions occur together. Autism spectrum features and attention difficulties are common alongside Fragile X syndrome, and early symptoms of Fragile X syndrome can be mistaken for autism alone. Anxiety, sensory sensitivities, and sleep problems may also occur, and when anxiety is active, learning and behavior issues can feel more intense. Some people with Fragile X syndrome also experience seizures (epilepsy), so neurologic care may be part of the plan, and connective-tissue traits like flexible joints or flat feet can contribute to pain or fatigue. Treating ADHD or anxiety symptoms can improve participation in school and therapies, while good seizure control can reduce regressions, so coordinated care across specialties usually makes a real difference.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children who learned to speak later than peers, struggled with attention, or seemed anxious in new settings, while other relatives had similar traits. Families sometimes recalled an uncle who needed extra support in school or a grandfather with a gentle manner and social shyness. Oral histories preserved these patterns long before a medical name existed.
First described in the medical literature as a form of inherited intellectual disability in the mid‑20th century, the condition was initially recognized through family trees that showed more boys than girls were affected. Early clinicians noted facial features that could become more noticeable with age and found that some boys had larger testes after puberty, which shaped the earliest reports. From these first observations, careful chromosome studies in the 1960s and 1970s revealed an unusual fragile site on the X chromosome when cells were grown under specific lab conditions, giving rise to the term Fragile X syndrome.
Advances in genetics in the 1980s and early 1990s clarified the underlying change: an expanded “CGG” repeat in a gene on the X chromosome that silences the gene’s function. This explained why symptoms could range from mild learning differences to more significant developmental delays, and why many girls and women had subtler features due to having two X chromosomes. It also showed why the condition could appear to “skip” generations—people carrying a smaller, premutation repeat often had no intellectual disability but could pass on an expanded repeat to their children.
Over time, descriptions became broader and more accurate. Clinicians recognized common behavioral features such as social anxiety, sensory sensitivities, and attention challenges, alongside strengths in imitation, humor, and visual learning. As medical science evolved, researchers also identified health concerns in some premutation carriers, including tremor and balance problems later in life or ovarian insufficiency, deepening the picture of how Fragile X–related conditions affect families across the lifespan.
In recent decades, awareness has grown, and testing shifted from looking for the fragile site under a microscope to precise DNA testing that counts CGG repeats. This change improved accuracy, allowed earlier diagnosis, and supported targeted educational and behavioral therapies. It also enabled clearer genetic counseling for families planning pregnancies.
Historical differences highlight why language and understanding matter. What was once labeled simply as “familial intellectual disability” is now known medically as Fragile X syndrome, with well‑defined genetic causes and a recognized spectrum of related conditions. Knowing the condition’s history helps explain today’s approach: offer early developmental support, screen for associated health issues, and provide family‑centered genetic information so relatives can make informed choices.